Low prevalence and disease severity of COVID‐19 in post‐liver transplant recipients—A single centre experience

Coronavirus disease 2019 (COVID‐19) caused by a novel coronavirus called severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is driving a present day global pandemic. Immunosuppressed patients are regarded as a high‐risk cohort. The following is a short report on COVID‐19 in liver transplan...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Anita, Khorsandi, Shirin Elizabeth, Dolcet, Annalisa, Prachalias, Andreas, Suddle, Abid, Heaton, Nigel, Jassem, Wayel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Cirrhosis, Liver Failure and Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300707/
https://www.ncbi.nlm.nih.gov/pubmed/32471013
http://dx.doi.org/10.1111/liv.14552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300707/
https://www.ncbi.nlm.nih.gov/pubmed/32471013
http://dx.doi.org/10.1111/liv.14552

Ejemplares similares